Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

OLK Stock. Modern Medical Research Laboratory: Two Scientists Wearing Face Masks use Microscope, Analyse Sample in Petri Dish, Talk. Advanced Scientific Lab for Medicine, Biotechnology. Blue Color. KZR stock. RSLS stock. Best Biotech Stocks to Buy

3 Biotech Stocks to Buy on the Dip: April 2024

If you follow Warren Buffett’s advice of being greedy when others are fearful, then it probably makes sense to consider biotech stocks to buy on…

image of a man running forward with arrows bearing down on him. For those who are interested in taking up the challenge of being contrarian investors, here are seven contrarian stocks to buy. Contrarian Stocks. contrarian investments

3 Contrarian Investments to Make Now for Massive Upside Potential

A combination of nervous investors and highly aggressive short sellers has made many contrarian investments quite attractive. 

An image of a street sign post with directions labeled "Buy", "Hold", and "Sell"

3 Long-Term Stocks to Buy on the Dip: April 2024

Pounce before it is too late! Build a robust portfolio with these three long-term stocks to buy on the dip.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Why Is Biodexa (BDRX) Up 70% Today?

By Josh Enomoto, InvestorPlace Contributor
Oncology specialist Biodexa inked a compelling licensing deal to treat a serious disease, and BDRX stock popped sharply higher.

Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts

By William White, InvestorPlace Writer
Bristol-Myers Squibb layoffs will see the company reduce its headcount by 6% as part of an effort to reduce expenses in 2024.

Why Is OptiNose (OPTN) Stock Up 12% Today?

By William White, InvestorPlace Writer
OptiNose stock is taking off on Thursday alongside an update on XHANCE that brings heavy trading to OPTN shares this morning.

The Only 3 Cannabis Stocks Sensible Investors Are Buying 

By Alex Sirois, InvestorPlace Contributor
Sensible investors will choose these cannabis stocks and others like them as the sector matures over the coming years.

The Blue-Chip Dip: 3 Safe Stocks to Scoop Up Before They Recover

By Terel Miles, InvestorPlace Contributor
With market volatility on the rise in the second quarter of 2024, investors should consider the best blue-chip stocks to scoop up this year.

7 Blue-Chip Stocks to Buy on the Dip: April 2024

By Thomas Niel, InvestorPlace Contributor
Each of these seven blue-chip stocks to buy on the dip offers high quality at a more-than-reasonable price.

3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition

By Chandler Capital, InvestorPlace Contributor
Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now.

Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses

By Shane Neagle, InvestorPlace Contributor
Explore the dynamics of money-maker stocks in 2024, which are fueled by AI advancements and robust economic growth.

Dirt-Cheap Delights: 3 Discounted Stocks That Could Triple by 2026

By Rick Orford, InvestorPlace Contributor
Investors looking for discounted stocks to reap big gains by 2026 might be interested in these three top-notch picks.

3 Biotech Stocks With Skyrocketing Potential: April 2024

By Muslim Farooque, InvestorPlace Contributor
These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time.

Why Is Amesite (AMST) Stock Up 74% Today?

By William White, InvestorPlace Writer
Amesite stock is up on Wednesday with heavy trading of AMST shares following the launch of a beta for its AI nurse assistant app.

The ‘Big Short’ Bargain Bin: 3 Michael Burry Stocks Worth Betting On

By Joey Frenette, InvestorPlace Contributor
The latest Michael Burry stocks seem to we worth owning for the long term if you seek value and long-term upside potential.

Cashing in on Cannabis: Why These 3 Weed Stocks Are Primed to Pop

By Rich Duprey, InvestorPlace Contributor
These three cannabis stocks are perfectly poised to capture the opportunity marijuana legalization in Germany represents.

Why Is Evotec (EVO) Stock Down 33% Today?

By William White, InvestorPlace Writer
Evotec stock is falling on Wednesday as EVO investors react to a lackluster 2024 revenue guidance in its 2023 earnings results.

3 Red-Hot Biotech Rockets Blasting Off in 2024

By Michael Que, InvestorPlace Contributor
The economy is looking very strong and the biotech industry even more so, thus consider these top three stocks for strong profits.

The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth

By Yiannis Zourmpanos, InvestorPlace Contributor
Discover the top dividend stocks for prolonged wealth in 2024 in pharmaceuticals, integrated telecommunications, drug retail, and tobacco.

3 Healthcare Stocks to Buy Now: Q2 Edition

By Viktor Zarev, InvestorPlace Contributor
Between an aging population and increased government spending, investors should consider these three healthcare stocks to buy now.

3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains

By Alex Sirois, InvestorPlace Contributor
These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly.

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

By Faisal Humayun, InvestorPlace Contributor
These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth.
Load More Articles